UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 8 Issue 8
August-2021
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2108458


Registration ID:
314262

Page Number

d714-d719

Share This Article


Jetir RMS

Title

Open Label Clinical Study on Treatment of Tamaka Shvasa/ Chronic Persistent Bronchial Asthma with Shvasakasaghna Dashemani gana drugs

Abstract

Prana/ Breathing is the primordial sign of life, which gets afflicted in Tamaka shvasa, which is caused by morbid kapha and vata dosha, originating from Pittasthana and manifesting through Pranavaha Srotas. Based on the clinical presentation, it can be correlated with Bronchial asthma, which is characterized by variable airflow obstruction with varied degree of dyspnoea, wheezing, cough and expectoration. Administration of Snigdha sweda, vamana, dhumapana and shamanoushadi in the succeeding order is the main line of treatment during the attack. Shamanoushadi is the main treatment modality, adopted during vega kala/attack, when patient is not fit for vamana. Shvasakasaghna Dashemani gana drugs have an edge over otherdrugs. 30 subjects suffering from Tamaka shvasa/Bronchial asthma were selected for the study after screening, based on the diagnostic, inclusion and exclusion criteria from OPD and IPD of SDM Ayurveda hospital, Udupi. Aqueous extract of Shvasakasaghna Dashemani Gana Drugs in 500mg vegetable capsule form were orally administered in a dose of 8 before food, morning and night with an after drink of warm water/milk for 28 days. The study showed remarkable remission in the severity of cough, dyspnoea, wheezing, chest tightness and improvement in the PEFR and asthma control test score with p value <0.001.

Key Words

Shvasakasaghna dashemani gana drugs, Tamaka shvasa, Bronchial asthma

Cite This Article

"Open Label Clinical Study on Treatment of Tamaka Shvasa/ Chronic Persistent Bronchial Asthma with Shvasakasaghna Dashemani gana drugs", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 8, page no.d714-d719, August-2021, Available :http://www.jetir.org/papers/JETIR2108458.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Open Label Clinical Study on Treatment of Tamaka Shvasa/ Chronic Persistent Bronchial Asthma with Shvasakasaghna Dashemani gana drugs", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 8, page no. ppd714-d719, August-2021, Available at : http://www.jetir.org/papers/JETIR2108458.pdf

Publication Details

Published Paper ID: JETIR2108458
Registration ID: 314262
Published In: Volume 8 | Issue 8 | Year August-2021
DOI (Digital Object Identifier):
Page No: d714-d719
Country: Udupi, Karnataka, India .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000538

Print This Page

Current Call For Paper

Jetir RMS